Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TNGX compared with SYRE: revenue, margins and what each company keeps, and the suppliers and customers both name
TNGX
Tango Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
SYRE
Spyre Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
TNGX
Tango Therapeutics, Inc.
vs
SYRE
Spyre Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
TNGX, solid
SYRE, dashed
TNGX
Tango Therapeutics, Inc.
Change
21.75
· pre 21.71
· delayed
Mkt cap
$3.7B
Revenue
$54M
Q3 FY25
Revenue
$42M
FY24
SYRE
Spyre Therapeutics, Inc.
Change
95.54
· pre 97.14
· delayed
Pre-market
Nov 3 '26
delayed
Mkt cap
$8.4B
Revenue
—
Revenue
—
vs
Compare
Pre-market
Nov 3 '26
delayed
TNGX
Tango Therapeutics, Inc.
vs
SYRE
Spyre Therapeutics, Inc.
21.75
pre 21.71
delayed
Price
95.54
pre 97.14
delayed
$3.7B
Mkt cap
$8.4B
Q3 FY25
$54M
Revenue
—
FY24
$42M
Revenue
—
Change
Change
TNGX
21.75
vs
SYRE
95.54
Pre-market
Nov 3 '26
delayed